Transaction in Own Shares

Eurocell plc
17 September 2024
 

EUROCELL PLC

("Eurocell" or the "Company")

 

Transaction in Own Shares

 

Eurocell announces that it has purchased (through Berenberg acting as the Company's broker) the following number of its ordinary shares of 0.1p each on the London Stock Exchange. The purchased shares will be held as treasury shares and used to satisfy employee share plans.

Date of purchase:

16/09/2024

Number of ordinary shares purchased (aggregated volume):

87,584

Highest price paid per share (pence):

163.50

Lowest price paid per share (pence):

163.00

Volume weighted average price paid per share (pence):

163.14

 

Following the purchase of these shares, the Company will have 910,258 shares held in treasury and the Company's issued share capital (excluding shares held as treasury shares) will consist of 104,087,060 shares.

The total number of voting rights in Eurocell is therefore 104,087,060. This figure may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest, or a change to their interest, in the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

Aggregate information:

Venue

Volume-weighted average price (pence per share)

Aggregated volume

XLON

163.14

87,584

 

Individual transactions:

Number of shares purchased

Transaction price
(pence per share)

Time of transaction

Venue

12,500

1.63

12:58

XLON

12,500

1.63

12:42

XLON

18,401

1.63

13:43

XLON

19,183

1.63

15:16

XLON

25,000

1.64

12:43

XLON

 

Enquiries:

 

Eurocell plc

Vicky Williams

Group Company Secretary

Tel: 01773 842100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Eurocell (ECEL)
UK 100

Latest directors dealings